Knowledge and Opinions of Saudi Dentists Regarding Dental Treatment of Patients Undergoing Bisphosphonates
Open Access
- 7 February 2020
- journal article
- research article
- Published by Georg Thieme Verlag KG in European Journal of Dentistry
- Vol. 14 (01) , 144-151
Abstract
Objectives Bisphosphonates (BPs) are used for treatment of various benign and malignant medical conditions. Medications-related osteonecrosis of the jaws (MRONJ) is a very serious complication of prolonged therapy with BPs. This study aimed to assess the level of knowledge among dental professionals in Saudi Arabia regarding MRONJ. Materials and Methods This was a questionnaire-based, cross-sectional study. A self-administered questionnaire comprising close-ended questions about BPs and MRONJ was sent to a convenience sample of dentists in Saudi Arabia.Statistical Analysis SPSS software was used for data analysis. Chi-square test was used to compare between the groups. The significance level was set at p < 0.05. Results A total of 607 dentists participated in this survey. Overall, the respondents showed insufficient level of knowledge regarding BPORNJ, with only 70% of the respondents had heard about BPORNJ, and less than 50% recognized the risk factors and clinical features of the disease. Additionally, while two-thirds of the respondents recognized the importance of taking BPs history, the majority did not know the correct treatment approach. Respondents with higher degrees (specialists) showed far better knowledge than general dentists. Conclusion The knowledge regarding BPs therapy and its complications among Saudi dentists is unsatisfactory. Hence, interventions are highly required to improve dentists’ knowledge regarding BPs and MRONJ.Keywords
This publication has 17 references indexed in Scilit:
- Knowledge of bisphosphonate-related osteonecrosis of the Jawsamong Mexican dentistsMedicina Oral Patología Oral y Cirugia Bucal, 2016
- Risks and Benefits of Bisphosphonate TherapiesJournal of Cellular Biochemistry, 2015
- Knowledge, Practices, and Opinions of Ontario Dentists When Treating Patients Receiving BisphosphonatesJournal of Oral and Maxillofacial Surgery, 2015
- Knowledge and attitudes of Brazilian dental students and dentists regarding bisphosphonate-related osteonecrosis of the jawSupportive Care in Cancer, 2015
- American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 UpdateJournal of Oral and Maxillofacial Surgery, 2014
- Survey of Korean dentists on the awareness on bisphosphonate‐related osteonecrosis of the jawsJournal of Investigative and Clinical Dentistry, 2010
- Oral Bisphosphonate–Associated Osteonecrosis of the Jaw After Implant Surgery: A Case Report and Literature ReviewJournal of Oral and Maxillofacial Surgery, 2010
- Bisphosphonate-Related Osteonecrosis of the Jaw: Clinical Features, Risk Factors, Management, and Treatment Outcomes of 26 PatientsJournal of Oral and Maxillofacial Surgery, 2009
- Denture-related osteonecrosis of the maxilla associated with oral bisphosphonate treatmentThe Journal of the American Dental Association, 2007
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003